Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium

Karlijn de Joode, Jolien Tol, the DOCC investigators, Paul Hamberg, Marissa Cloos, Elisabeth A. Kastelijn, Jessica S.W. Borgers, Veerle J.A.A. Nuij, Yarne Klaver, Gerarda J.M. Herder, Pim G.N.J. Mutsaers, Daphne W. Dumoulin, Esther Oomen-de Hoop, Nico G.J. van Diemen, Eduard J. Libourel, Erica J. Geraedts, Gerben P. Bootsma, Cor H. van der Leest, Anne L. Peerdeman, Karin H. HerbschlebOtto J. Visser, Haiko J. Bloemendal, Hanneke W.M. van Laarhoven, Elisabeth G.E. de Vries, Lizza E.L. Hendriks, Laurens V. Beerepoot, Hans M. Westgeest, Franchette W.P.J. van den Berkmortel, Anne Marie C. Dingemans, Astrid A.M. van der Veldt*, L. van Leeuwen, F. S. van der Meer, M. A. Tiemessen, D. M. van Diepen, P. Brocken, J. C. Drooger, J. W.B. de Groot, J. A. Stigt, M. Slingerland, B. C.M. Haberkorn, M. J.B. Aarts, M. Youssef, L. M. Faber, R. A.W. van de Wetering, M. P.L. Bard, G. Douma, K. P.M. Suijkerbuijk, S. D. Bakker, W. K. de Jong, A. J. Staal, B. Franken

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)
34 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium'. Together they form a unique fingerprint.

Medicine and Dentistry